With the health care debate continuing, how can investors make money in the sector? Barbara Ryan, managing director and senior pharmaceuticals analyst at Deutsche Bank Securities, and Charles Boorady, health care providers analyst at Citigroup, shared their insights.   Read More

Following are the day’s biggest winners and losers. Find out why shares of Burlington Northern and AIG popped while Kraft Foods dropped.   Read More

Following are the day’s biggest winners and losers. Find out why shares of IMS Health and Lamar Advertising popped while American Eagle and Whole Foods Market dropped.   Read More

Stocks jumped on Wednesday on positive economic data. Now, investors are waiting to hear from the Fed at 2:15pm. Will they confirm or deny the rally?   Read More

You’ve heard it before, but a health care bill looks likely to pass the House that would create a public option and ultimately cover at least 95% of the nation.   Read More

In a setback for progressives, Maine Sen. Olympia Snowe said she would vote with fellow Republicans to block the Democratic health care overhaul...   Read More

Despite what you’ve heard, the public option might not be off the table after all.    Read More

Tuesday could well be remembered as a turning point in our nation’s efforts to reform health care.   Read More

When the etymology of the word “chutzpah” is recorded, Karen Ignagni, who heads the American Health Insurance Plans industry group, will surely earn an honorable mention. On the eve of the Senate Finance Committee’s vote to reform health care, AHIP released a report claiming that committee’s legislation will raise premiums on the average family by thousands of dollars.    Read More

Worries over health care reform have caused the sector to be underowned, but there are still opportunities for investors looking to take advantage of the low prices, said Charles Boorady of Citigroup and Arthur Henderson of Jeffries & Co.    Read More